1-855-378-42281-855-378-4228
One of the outpatient rehabilitation alternatives for clients in Valentine struggling with opioid dependence and addiction is opioid maintenance therapy. Licensed clinics and doctors are certified to give specific medications to opioid dependent people, many of which are opioids themselves and are addictive. In low amounts however, the individual does not experience high feelings and also does not have intense cravings and isn't in opioid withdrawal. Methadone is the first medication tried for this reason, but there are a few more choices currently to choose from.
Methadone is an opiate and can be taken at an out-patient medical center licensed to dispense the med, that is taken daily as a pill or liquid. The price of the med is approximately $150 monthly. Buprenorphine is also an opioid-based med, and is a pill often taken one day on, one day off. But different from Methadone which is only be given in highly structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is around three hundred dollars monthly for the generic version of the med. There is also a type of buprenorphine that contains the ingredient naloxone, which is a med which blocks the effects of opiates. A person consuming this version of the drug, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced around $450 monthly. Naltrexone is an additional med used in opioid maintenance therapy, but unlike the other medications mentioned it's an opioid blocker and isn't an opiate. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from getting high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Drug and Alcohol Rehabilitation Centers In Valentine, Click Here.
